Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

BL, ? 4.1mm RC, SLA? 8mm, TiZr, NTP: medical device reports filed with FDA

8,083 reports name it, 2019–2026. Manufacturer given most often on reports: Institut Straumann. Product code DZE.

8,083
device reports naming the brand
0% of all MAUDE reports · about 1,169 a year
1,223
reports, 12 months to August 2026
1,327 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 8,083 reports that name the brand "BL, ? 4.1mm RC, SLA? 8mm, TiZr, NTP" (endosseous dental implant), received between August 2019 and August 2026; the manufacturer given most often on reports is Institut Straumann. Spellings of one product vary from report to report.

1,223 reports arrived in the 12 months to August 2026, close to the 1,327 of the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (65.3%), loss of osseointegration (30%) and difficult to insert (0.7%). The patient problems coded most often are fibrosis, pain and tissue damage. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0135269Sep 2021: 54Oct 2021: 69Nov 2021: 91Dec 2021: 742022Jan 2022: 78Feb 2022: 70Mar 2022: 102Apr 2022: 91May 2022: 111Jun 2022: 77Jul 2022: 78Aug 2022: 137Sep 2022: 118Oct 2022: 99Nov 2022: 82Dec 2022: 1222023Jan 2023: 103Feb 2023: 103Mar 2023: 109Apr 2023: 109May 2023: 88Jun 2023: 111Jul 2023: 112Aug 2023: 115Sep 2023: 66Oct 2023: 99Nov 2023: 84Dec 2023: 742024Jan 2024: 87Feb 2024: 83Mar 2024: 110Apr 2024: 152May 2024: 102Jun 2024: 104Jul 2024: 124Aug 2024: 108Sep 2024: 76Oct 2024: 174Nov 2024: 181Dec 2024: 1132025Jan 2025: 86Feb 2025: 98Mar 2025: 91Apr 2025: 36May 2025: 0Jun 2025: 269Jul 2025: 113Aug 2025: 90Sep 2025: 102Oct 2025: 129Nov 2025: 95Dec 2025: 1222026Jan 2026: 102Feb 2026: 57Mar 2026: 105Apr 2026: 103May 2026: 123Jun 2026: 113Jul 2026: 92Aug 2026: 80

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

07071,4142019: 65220192020: 74920202021: 92420212022: 1,16520222023: 1,17320232024: 1,41420242025: 1,23120252026: 7752026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%8,083
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report90%7,277
Voluntary report0%0
User facility report0%0
Distributor report10%806
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate5,27765.3%62.8%
Loss of osseointegration2,42530%22.4%
Difficult to insertthe device was hard to insert580.7%0.4%
Fracturea broken bone500.6%1.6%
Unintended movement160.2%0%
Difficult to removethe device was hard to remove70.1%0%
Unstable50.1%0%
Therapeutic or diagnostic output failure40%0%
Separation failure30%0.1%
Activation, positioning or separation problem20%0%
Defective devicethe device was defective20%0%
Output problem10%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Fibrosis2,76634.2%
Painpain, site not specified1,70321.1%
Tissue damage89311%
Inflammationinflammation6077.5%
Swelling/ edema4986.2%
Hemorrhage/blood loss/bleeding4876%
Fistula2823.5%
Abscessa collection of pus2212.7%
Hyperresponsive to stimuli1952.4%
Hypersensitivity/allergic reaction891.1%
Swellingswelling791%
Sinus perforation490.6%
Failure of implant410.5%
Numbnessnumbness350.4%
Increased sensitivity300.4%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureBL, ? 4.1mm RC, SLA? 8mm, TiZr, NTPProduct code DZEAll MAUDE reports
Reports8,0833,924,24126,136,888
Share of that pool—0.2%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer90%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about BL, ? 4.1mm RC, SLA? 8mm, TiZr, NTP reports

How many FDA reports name BL, ? 4.1mm RC, SLA? 8mm, TiZr, NTP?

8,083 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 1,223 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (65.3%), loss of osseointegration (30%), difficult to insert (0.7%), fracture (0.6%) and unintended movement (0.2%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (90%) and distributor reports (10%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that BL, ? 4.1mm RC, SLA? 8mm, TiZr, NTP was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.